Industry
Medical - Instruments & Supplies
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
Loading...
Open
17.90
Mkt cap
1.2B
Volume
206K
High
20.11
P/E Ratio
-23.94
52-wk high
22.69
Low
17.84
Div yield
N/A
52-wk low
4.57
Portfolio Pulse from Benzinga Insights
November 01, 2024 | 4:36 pm
Portfolio Pulse from Benzinga Newsdesk
October 31, 2024 | 6:51 pm
Portfolio Pulse from Benzinga Newsdesk
October 31, 2024 | 6:26 pm
Portfolio Pulse from Benzinga Newsdesk
October 30, 2024 | 8:53 pm
Portfolio Pulse from Avi Kapoor
August 13, 2024 | 3:44 pm
Portfolio Pulse from Benzinga Newsdesk
August 12, 2024 | 8:02 pm
Portfolio Pulse from Benzinga Newsdesk
August 08, 2024 | 12:35 pm
Portfolio Pulse from Benzinga Newsdesk
July 08, 2024 | 12:02 pm
Portfolio Pulse from Benzinga Newsdesk
June 28, 2024 | 12:05 pm
Portfolio Pulse from Benzinga Newsdesk
June 04, 2024 | 12:12 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.